117 related articles for article (PubMed ID: 23262168)
1. Cost of hospitalizing children with invasive pneumococcal pneumonia.
Brotons P; Gelabert G; Launes C; Sicuri E; Pallares R; Muñoz-Almagro C
Vaccine; 2013 Feb; 31(7):1117-22. PubMed ID: 23262168
[TBL] [Abstract][Full Text] [Related]
2. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of pneumonia hospitalizations in Spain, 1995-1998.
Gil A; San-Martín M; Carrasco P; González A
J Infect; 2002 Feb; 44(2):84-7. PubMed ID: 12076066
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.
Cillóniz C; Ewig S; Polverino E; Muñoz-Almagro C; Marco F; Gabarrús A; Menéndez R; Mensa J; Torres A
Clin Microbiol Infect; 2012 Nov; 18(11):1134-42. PubMed ID: 22044658
[TBL] [Abstract][Full Text] [Related]
5. [Bacteremic pneumococcal pneumonia].
Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.
Blank PR; Szucs TD
Vaccine; 2012 Jun; 30(28):4267-75. PubMed ID: 22521287
[TBL] [Abstract][Full Text] [Related]
7. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
8. Trends in US hospital stays for Streptococcus pneumoniae-associated hemolytic uremic syndrome.
Veesenmeyer AF; Edmonson MB
Pediatr Infect Dis J; 2013 Jul; 32(7):731-5. PubMed ID: 23838775
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines.
De Schutter I; Malfroot A; Piérard D; Lauwers S
Pediatr Pulmonol; 2006 Aug; 41(8):765-70. PubMed ID: 16779850
[TBL] [Abstract][Full Text] [Related]
10. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
Zhou F; Kyaw MH; Shefer A; Winston CA; Nuorti JP
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1162-8. PubMed ID: 18056561
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population.
Wexler ID; Knoll S; Picard E; Villa Y; Shoseyov D; Engelhard D; Kerem E
Pediatr Pulmonol; 2006 Aug; 41(8):726-34. PubMed ID: 16779839
[TBL] [Abstract][Full Text] [Related]
12. [Study of hospitalizations for pneumococcal pneumoniae in Centre region, 2004-2008].
Grammatico-Guillon L; Thiercelin N; Mariani S; Lecuyer AI; Goudeau A; Bernard L; Rusch E
Rev Epidemiol Sante Publique; 2012 Feb; 60(1):1-8. PubMed ID: 22245493
[TBL] [Abstract][Full Text] [Related]
13. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
15. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.
Langley JM; Kellner JD; Solomon N; Robinson JL; Le Saux N; McDonald J; Ulloa-Gutierrez R; Tan B; Allen U; Dobson S; Joudrey H
BMC Infect Dis; 2008 Sep; 8():129. PubMed ID: 18816409
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.
Díez-Domingo J; Pereiró I; Morant A; Gimeno C; Lerma M; Oyagüez I; González A;
J Infect; 2002 Oct; 45(3):139-43. PubMed ID: 12387768
[TBL] [Abstract][Full Text] [Related]
18. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
[TBL] [Abstract][Full Text] [Related]
19. [Study of the incidence of invasive pneumococcal disease in neonates and childre aged less than 5 years in the Basque country and Navarre (Spain)].
Bernaola Iturbe E; Aristegui Fernández Jd; Herranz Aguirre M; García Calvo C; Fernández Pérez C;
An Esp Pediatr; 2002 Oct; 57(4):301-9. PubMed ID: 12392663
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
